Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 14

1.

Should patient characteristics influence target anticoagulation intensity for stroke prevention in nonvalvular atrial fibrillation?: the ATRIA study.

Singer DE, Chang Y, Fang MC, Borowsky LH, Pomernacki NK, Udaltsova N, Go AS.

Circ Cardiovasc Qual Outcomes. 2009 Jul;2(4):297-304. doi: 10.1161/CIRCOUTCOMES.108.830232. Epub 2009 Jun 9.

2.

Warfarin anticoagulation and outcomes in patients with atrial fibrillation: a systematic review and metaanalysis.

Reynolds MW, Fahrbach K, Hauch O, Wygant G, Estok R, Cella C, Nalysnyk L.

Chest. 2004 Dec;126(6):1938-45. Review.

PMID:
15596696
3.
4.

Optimal INR for prevention of stroke and death in atrial fibrillation: a critical appraisal.

Odén A, Fahlén M, Hart RG.

Thromb Res. 2006;117(5):493-9. Epub 2004 Dec 25. Review.

PMID:
16517250
5.

Use of novel oral anticoagulants for patients with atrial fibrillation: systematic review and clinical implications.

Albert NM.

Heart Lung. 2014 Jan-Feb;43(1):48-59. doi: 10.1016/j.hrtlng.2013.10.014. Epub 2013 Nov 11. Review.

PMID:
24373340
6.

[Atrial fibrillation and thromboembolic events prevention. State of the art].

Matteoli S, Trappolini M, Chillotti FM.

Minerva Cardioangiol. 2001 Feb;49(1):1-13. Review. Italian.

PMID:
11279381
7.

Prevention of thromboembolic events in atrial fibrillation.

Koefoed BG, Gulløv AL, Petersen P.

Thromb Haemost. 1997 Jul;78(1):377-81. Review.

PMID:
9198182
8.

Current trial-associated outcomes with warfarin in prevention of stroke in patients with nonvalvular atrial fibrillation: a meta-analysis.

Agarwal S, Hachamovitch R, Menon V.

Arch Intern Med. 2012 Apr 23;172(8):623-31; discussion 631-3. doi: 10.1001/archinternmed.2012.121. Epub 2012 Mar 26. Review.

PMID:
22450212
9.

Cognitive impairment as determinant for sub-optimal control of oral anticoagulation treatment in elderly patients with atrial fibrillation.

van Deelen BA, van den Bemt PM, Egberts TC, van 't Hoff A, Maas HA.

Drugs Aging. 2005;22(4):353-60. Review.

PMID:
15839723
10.

Approach to and management of the acute stroke patient with atrial fibrillation: a literature review.

Marmagkiolis K, Nikolaidis IG, Politis T, Goldstein L.

J Hosp Med. 2008 Jul;3(4):326-32. doi: 10.1002/jhm.343. Review.

PMID:
18698609
11.

Brain microbleeds, anticoagulation, and hemorrhage risk: Meta-analysis in stroke patients with AF.

Charidimou A, Karayiannis C, Song TJ, Orken DN, Thijs V, Lemmens R, Kim J, Goh SM, Phan TG, Soufan C, Chandra RV, Slater LA, Haji S, Mok V, Horstmann S, Leung KT, Kawamura Y, Sato N, Hasebe N, Saito T, Wong LKS, Soo Y, Veltkamp R, Flemming KD, Imaizumi T, Srikanth V, Heo JH; International META-MICROBLEEDS Initiative.

Neurology. 2017 Dec 5;89(23):2317-2326. doi: 10.1212/WNL.0000000000004704. Epub 2017 Nov 8. Review.

PMID:
29117953
12.

Restarting Anticoagulant Therapy After Intracranial Hemorrhage: A Systematic Review and Meta-Analysis.

Murthy SB, Gupta A, Merkler AE, Navi BB, Mandava P, Iadecola C, Sheth KN, Hanley DF, Ziai WC, Kamel H.

Stroke. 2017 Jun;48(6):1594-1600. doi: 10.1161/STROKEAHA.116.016327. Epub 2017 Apr 17. Review.

PMID:
28416626
13.

MRI screening for chronic anticoagulation in atrial fibrillation.

Fisher M.

Front Neurol. 2013 Oct 4;4:137. doi: 10.3389/fneur.2013.00137. Review.

14.

Supplemental Content

Support Center